These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25494412)

  • 1. Correlation between gamma index passing rate and clinical dosimetric difference for pre-treatment 2D and 3D volumetric modulated arc therapy dosimetric verification.
    Jin X; Yan H; Han C; Zhou Y; Yi J; Xie C
    Br J Radiol; 2015 Mar; 88(1047):20140577. PubMed ID: 25494412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis.
    Sun WZ; Zhang DD; Peng YL; Chen L; Kang DH; Wang B; Deng XW
    Radiat Oncol; 2018 Mar; 13(1):42. PubMed ID: 29544512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual volume-based 3D gamma indices for pretreatment VMAT QA.
    Yi J; Han C; Zheng X; Zhou Y; Deng Z; Xie C; Jin X; Jin F
    J Appl Clin Med Phys; 2017 May; 18(3):28-36. PubMed ID: 28318101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study on the effect of detector resolution on gamma index passing rate for VMAT and IMRT QA.
    Woon W; Ravindran PB; Ekayanake P; S V; Lim YY; Khalid J
    J Appl Clin Med Phys; 2018 Mar; 19(2):230-248. PubMed ID: 29460465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment patient-specific IMRT quality assurance: a correlation study between gamma index and patient clinical dose volume histogram.
    Stasi M; Bresciani S; Miranti A; Maggio A; Sapino V; Gabriele P
    Med Phys; 2012 Dec; 39(12):7626-34. PubMed ID: 23231310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-treatment 2D and 3D dosimetric verification of volumetric arc therapy. A correlation study between gamma index passing rate and clinical dose volume histogram.
    Szczurek L; Juszkat R; Szczurek J; Turek I; Sosnowski P
    PLoS One; 2019; 14(8):e0221086. PubMed ID: 31408486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of TG-218 for patient-specific quality assurance tolerance and action limits determination: Gamma passing rate evaluation using 3DVH software.
    Stasinou D; Patatoukas G; Kollaros N; Diamantopoulos S; Kypraiou E; Kougioumtzopoulou A; Kouloulias V; Efstathopoulos E; Platoni K
    Med Phys; 2022 Jul; 49(7):4322-4334. PubMed ID: 35560362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of DVH-based plan verification methods for VMAT: ArcCHECK-3DVH system and dynalog-based dose reconstruction.
    Saito M; Kadoya N; Sato K; Ito K; Dobashi S; Takeda K; Onishi H; Jingu K
    J Appl Clin Med Phys; 2017 Jul; 18(4):206-214. PubMed ID: 28649722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of volumetric modulated arc therapy patient specific QA results to multileaf collimator errors and correlation to dose volume histogram based metrics.
    Coleman L; Skourou C
    Med Phys; 2013 Nov; 40(11):111715. PubMed ID: 24320423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial experience of ArcCHECK and 3DVH software for RapidArc treatment plan verification.
    Infusino E; Mameli A; Conti R; Gaudino D; Stimato G; Bellesi L; D'Angelillo RM; Ramella S; Benassi M; Trodella L
    Med Dosim; 2014; 39(3):276-81. PubMed ID: 25088815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative evaluation of 3D dosimetry for stereotactic volumetric-modulated arc delivery using COMPASS.
    Vikraman S; Manigandan D; Karrthick KP; Sambasivaselli R; Senniandavar V; Ramu M; Rajesh T; Lutz M; Muthukumaran M; Karthikeyan N; Tejinder K
    J Appl Clin Med Phys; 2014 Jan; 16(1):5128. PubMed ID: 25679152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Composite QA for intensity-modulated radiation therapy using individual volume-based 3D gamma indices.
    Han C; Yu W; Zheng X; Zhou Y; Gong C; Xie C; Jin X
    J Radiat Res; 2018 Sep; 59(5):669-676. PubMed ID: 30085157
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
    Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach to EPID-based 3D volumetric dosimetry for IMRT and VMAT QA.
    Alhazmi A; Gianoli C; Neppl S; Martins J; Veloza S; Podesta M; Verhaegen F; Reiner M; Belka C; Parodi K
    Phys Med Biol; 2018 May; 63(11):115002. PubMed ID: 29714714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of gamma index based on dosimetric error and clinically relevant dose-volume index based on three-dimensional dose prediction in breast intensity-modulated radiation therapy.
    Kaneko A; Sumida I; Mizuno H; Isohashi F; Suzuki O; Seo Y; Otani K; Tamari K; Ogawa K
    Radiat Oncol; 2019 Feb; 14(1):36. PubMed ID: 30808377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VMAT QA: measurement-guided 4D dose reconstruction on a patient.
    Nelms BE; Opp D; Robinson J; Wolf TK; Zhang G; Moros E; Feygelman V
    Med Phys; 2012 Jul; 39(7):4228-38. PubMed ID: 22830756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of ArcCheck and film verification for VMAT in the treatment of nasopharyngeal carcinoma].
    Yi J; Jin X; Zhou Y; Han C; Zheng X; Wu Z; Huang K; Xie C
    Zhongguo Yi Liao Qi Xie Za Zhi; 2013 May; 37(3):228-31. PubMed ID: 24015624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation analysis between 2D and quasi-3D gamma evaluations for both intensity-modulated radiation therapy and volumetric modulated arc therapy.
    Kim JI; Choi CH; Wu HG; Kim JH; Kim K; Park JM
    Oncotarget; 2017 Jan; 8(3):5449-5459. PubMed ID: 27690300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of plan parameters on the dosimetric accuracy of volumetric modulated arc therapy.
    Masi L; Doro R; Favuzza V; Cipressi S; Livi L
    Med Phys; 2013 Jul; 40(7):071718. PubMed ID: 23822422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of constant dose rate VMAT in the treatment of nasopharyngeal cancer patients.
    Yu W; Shang H; Xie C; Han C; Yi J; Zhou Y; Jin X
    Radiat Oncol; 2014 Nov; 9():235. PubMed ID: 25366034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.